A pilot survey presented at the Respiratory Drug Delivery Europe conference in April in Paris, revealed that health care professionals are receiving the latest pressurised metered dose inhaler (pMDI) from Bang & Olufsen Medicom, Insulair®, with enthusiasm. The overall feedback on the inhaler device is very positive and the specific features offered with Insulair® are evaluated as crucial features for a successful inhaler device. The respondents were impressed by the overall concept, its ease of use and especially the integrated dose counter function as well as its breath-actuation principle.

Download the pilot survey on Insulair® or read more about the inhaler range from B&O Medicom. 

Return to main headlines